These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16284682)

  • 1. Severe upper limb complications from parenteral abuse of Subutex.
    Loo HW; Yam AK; Tan TC; Peng YP; Teoh LC
    Ann Acad Med Singap; 2005 Oct; 34(9):575-8. PubMed ID: 16284682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another complication of subutex abuse.
    Joethy J; Yong FC; Puhaindran M
    Singapore Med J; 2008 Mar; 49(3):267-8. PubMed ID: 18363014
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical complications in parenteral Subutex abusers.
    Lo HY; Leong CS
    Singapore Med J; 2006 Nov; 47(11):924-7. PubMed ID: 17075657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopathology of the misuse of Subutex®: The Popeye syndrome].
    Békaert J; Podevin G
    Encephale; 2015 Jun; 41(3):229-37. PubMed ID: 25212472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of infected pseudoaneurysms in intravenous drug abusers: single institution experience and a proposed algorithm.
    Tan KK; Chen K; Chia KH; Lee CW; Nalachandran S
    World J Surg; 2009 Sep; 33(9):1830-5. PubMed ID: 19597874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications relating to intravenous buprenorphine abuse: a single institution case series.
    Yeo AK; Chan CY; Chia KH
    Ann Acad Med Singap; 2006 Jul; 35(7):487-91. PubMed ID: 16902725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets.
    Feeney GF; Fairweather P
    Drug Alcohol Rev; 2003 Sep; 22(3):359-61. PubMed ID: 15385230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Necrotic livedo after injection of buprenorphine (Subutex)].
    Potier A; Leclech C; Croue A; Chappard D; Verret JL
    Ann Dermatol Venereol; 2007 Feb; 134(2):148-50. PubMed ID: 17375011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infective endocarditis secondary to intravenous Subutex abuse.
    Chong E; Poh KK; Shen L; Yeh IB; Chai P
    Singapore Med J; 2009 Jan; 50(1):34-42. PubMed ID: 19224082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine diversion: a possible reason for increased incidence of infective endocarditis among injection drug users? The Singapore experience.
    Chai LY; Khare CB; Chua A; Fisher DA; Tambyah PA
    Clin Infect Dis; 2008 Mar; 46(6):953-5; author reply 955-6. PubMed ID: 18288906
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous Injection of Percocet: A Case of Severe Soft Tissue Loss.
    Baskin SM; Abboud C; Chen W; Tolchin E; Kelly RW; Aballay AM
    Wounds; 2015 Jul; 27(7):174-9. PubMed ID: 26192735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peritonitis after high-dose buprenorphine (Subutex) use: apropos of a case].
    Nguyen N; Spadari M; Ruiz JM; Camprasse MA; Galinier A; Jean-Pastor MJ; Valli M
    Therapie; 2003; 58(5):469-71. PubMed ID: 14682200
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual complication of intravenous Subutex abuse: two cases of septic sacroiliitis.
    Yang SS; Lee K
    Singapore Med J; 2008 Dec; 49(12):e343-6. PubMed ID: 19122930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse of buprenorphine in the United States: 2003-2005.
    Smith MY; Bailey JE; Woody GE; Kleber HD
    J Addict Dis; 2007; 26(3):107-11. PubMed ID: 18018814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex).
    Cassoux N; Bodaghi B; Lehoang P; Edel Y
    Br J Ophthalmol; 2002 Aug; 86(8):940-1. PubMed ID: 12140228
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended.
    Nielsen S; Lintzeris N
    Addiction; 2008 Dec; 103(12):2065-6. PubMed ID: 19469751
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous complications among i.v. buprenorphine users.
    Ho RC; Ho EC; Mak A
    J Dermatol; 2009 Jan; 36(1):22-9. PubMed ID: 19207433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe distal ischemic syndrome after buprenorphine volunteer intra-arterial injection].
    Glaizal M; Lucciardi J; Tichadou L; Spadari M; Hayek-Lanthois M; Micallef J; de Haro L
    Therapie; 2011; 66(6):545-7. PubMed ID: 22186079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in first episode infective endocarditis among intravenous buprenorphine users: case report.
    Ho RC; Ho EC; Tan CH; Mak A
    Am J Drug Alcohol Abuse; 2009; 35(3):199-202. PubMed ID: 19462305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.